Minireview: Extrapituitary prolactin: An update on the distribution, regulation, and functions

Molecular Endocrinology

Volumn 28, Issue 5, 2014, Pages 622-633

  Marano, Robert J ^a,b   Ben Jonathan, Nira ^c  

^a Ear Science Institute Australia   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROLACTIN; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; CELL FUNCTION; DECIDUA; ENDOTHELIUM CELL; GENDER BIAS; GENE EXPRESSION REGULATION; HAIR FOLLICLE; HORMONAL REGULATION; HUMAN; IMMUNE SYSTEM; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; ANIMAL; ANTIBODY SPECIFICITY; BRAIN; FEMALE; MALE; MAMMARY GLAND; METABOLISM; OVARY; PHYSIOLOGY; SECRETION (PROCESS); TESTIS;

ANIMALS; BRAIN; DECIDUA; FEMALE; HUMANS; IMMUNE SYSTEM; MALE; MAMMARY GLANDS, HUMAN; ORGAN SPECIFICITY; OVARY; PROLACTIN; TESTIS;

EID: 84899757572     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2013-1349     Document Type: Review

References (99)

1. Hiraoka Y, Tatsumi K, Shiozawa M, et al. A placenta-specific 5 non-coding exon of human prolactin. Mol Cell Endocrinol. 1991; 75: 71-80.
2. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol. 1994; 8: 356-373.
3. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996; 17: 639-669.
4. Arendt LM, Schuler LA. Transgenic models to study actions of prolactin in mammary neoplasia. J Mammary Gland Biol Neoplasia. 2008; 13: 29-40.
5. Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocr Rev. 2008; 29: 1-41.
6. Clevenger CV, Plank TL. Prolactin as an autocrine/paracrine factor in breast tissue. J Mammary Gland Biol Neoplasia. 1997; 2: 59-68.
7. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev. 2003; 24: 1-27.
8. Harvey PW. Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific. J Appl Toxicol. 2012; 32: 1-9.
9. Goffin V, Hoang DT, Bogorad RL, Nevalainen MT. Prolactin regulation of the prostate gland: a female player in a male game. Nat Rev Urol. 2011; 8: 597-607.
10. Harvey PW, Everett DJ, Springall CJ. Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol. 2008; 22: 20-27.
11. Montgomery DW. Prolactin production by immune cells. Lupus. 2001; 10: 665-675.
12. Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev. 2007; 6: 537-542.
13. Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R. Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab. 2010; 21: 569-577.
14. Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007; 9: 464-476.
15. Tanaka S, Koibuchi N, Ohtake H, et al. Regional comparison of prolactin gene expression in the human decidualized endometrium in early and term pregnancy. Eur J Endocrinol. 1996; 135: 177-183.
16. Bao L, Tessier C, Prigent-Tessier A, et al. Decidual prolactin silences the expression of genes detrimental to pregnancy. Endocrinology. 2007; 148: 2326-2334.
17. Eyal O, Jomain JB, Kessler C, Goffin V, Handwerger S. Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin. Biol Reprod. 2007; 76: 777-783.
18. Jones RL, Critchley HO, Brooks J, Jabbour HN, McNeilly AS. Localization and temporal expression of prolactin receptor in human endometrium. J Clin Endocrinol Metab. 1998; 83: 258-262.
19. Maaskant RA, Bogic LV, Gilger S, Kelly PA, Bryant-Greenwood GD. The human prolactin receptor in the fetal membranes, decidua, and placenta. J Clin Endocrinol Metab. 1996; 81: 396-405.
20. Brar AK, Frank GR, Kessler CA, Cedars MI, Handwerger S. Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Endocrine. 1997; 6: 301-307.
21. Telgmann R, Maronde E, Taskén K, Gellersen B. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Endocrinology. 1997; 138: 929-937.
22. Pohnke Y, Kempf R, Gellersen B. CCAAT/enhancer-binding proteins are mediators in the protein kinase A-dependent activation of the decidual prolactin promoter. J Biol Chem. 1999; 274: 24808-24818.
23. Watanabe K, Kessler CA, Bachurski CJ, et al. Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites. Mol Endocrinol. 2001; 15: 638-653.
24. Brar AK, Kessler CA, Handwerger S. An Ets motif in the proximal decidual prolactin promoter is essential for basal gene expression. J Mol Endocrinol. 2002; 29: 99-112.
25. Butticè G, Duterque-Coquillaud M, Basuyaux JP, Carrère S, Kurkinen M, Stéhelin D. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene. 1996; 13: 2297-2306.
26. Kessler CA, Bachurski CJ, Schroeder J, Stanek J, Handwerger S. TEAD1 inhibits prolactin gene expression in cultured human uterine decidual cells. Mol Cell Endocrinol. 2008; 295: 32-38.
27. Jiang Y, Hu Y, Zhao J, Zhen X, Yan G, Sun H. The orphan nuclear receptor Nur77 regulates decidual prolactin expression in human endometrial stromal cells. Biochem Biophys Res Commun. 2011; 404: 628-633.
28. Kumari M, Heffner LJ. The effects of L-arginine on the release of prolactin from decidual explants in vitro. Am J Obstet Gynecol. 2000; 182: 497-502.
29. Christian M, Marangos P, Mak I, et al. Interferon-γ modulates prolactin and tissue factor expression in differentiating human endometrial stromal cells. Endocrinology. 2001; 142: 3142-3151.
30. Kanda Y, Jikihara H, Markoff E, Handwerger S. Interleukin-2 inhibits the synthesis and release of prolactin from human decidual cells. J Clin Endocrinol Metab. 1999; 84: 677-681.
31. Fluhr H, Krenzer S, Deperschmidt M, Zwirner M, Wallwiener D, Licht P. Human chorionic gonadotropin inhibits insulin-like growth factor-binding protein-1 and prolactin in decidualized human endometrial stromal cells. Fertil Steril. 2006; 86: 236-238.
32. Christian M, Zhang X, Schneider-Merck T, et al. Cyclic AMPinduced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein β in differentiating human endometrial stromal cells. J Biol Chem. 2002; 277: 20825-20832.
33. Lynch VJ, Brayer K, Gellersen B, Wagner GP. HoxA-11 and FOXO1A cooperate to regulate decidual prolactin expression: towards inferring the core transcriptional regulators of decidual genes. PLoS One. 2009; 4: e6845.
34. Yasui Y, Yamaguchi M, Jikihara H, Yamamoto T, Kanzaki T, Murata Y. Expression of prolactin-releasing peptide in human placenta and decidua. Endocr J. 2001; 48: 397-401.
35. Lin SH. Prolactin-releasing peptide. Results Probl Cell Differ. 2008; 46: 57-88.
36. Reis FM, Viganò P, Arnaboldi E, Spritzer PM, Petraglia F, Di Blasio AM. Expression of prolactin-releasing peptide and its receptor in the human decidua. Mol Hum Reprod. 2002; 8: 356-362.
37. Shaw-Bruha CM, Pirrucello SJ, Shull JD. Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Res Treat. 1997; 44: 243-253.
38. Zinger M, McFarland M, Ben-Jonathan N. Prolactin expression and secretion by human breast glandular and adipose tissue explants. J Clin Endocrinol Metab. 2003; 88: 689-696.
39. Chen CC, Stairs DB, Boxer RB, et al. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev. 2012; 26: 2154-2168.
40. Imaoka T, Matsuda M, Mori T. Expression of prolactin messenger ribonucleic acid in the mouse gonads during sexual maturation. Life Sci. 1998; 63: 2251-2258.
41. Schwärzler P, Untergasser G, Hermann M, Dirnhofer S, Abendstein B, Berger P. Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril. 1997; 68: 696-701.
42. Phelps JY, Bugg EM, Shamblott MJ, Vlahos NP, Whelan J, Zacur HA. Prolactin gene expression in human ovarian follicular cells. Fertil Steril. 2003; 79: 182-185.
43. Romão GS, Ferriani RA, Moura MD, Martins AR. Screening for prolactin isoforms in the follicular fluid of patients undergoing in vitro fertilization. Gynecol Obstet Invest. 2002; 54: 46-49.
44. Erdmann S, Ricken A, Merkwitz C, et al. The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle. AmJ Physiol Endocrinol Metab. 2007; 293: E1365-E1377.
45. Shibaya M, Murakami S, Tatsukawa Y, Skarzynski DJ, Acosta TJ, Okuda K. Bovine corpus luteum is an extrapituitary site of prolactin production. Mol Reprod Dev. 2006; 73: 512-519.
46. Nevalainen MT, Valve EM, Ahonen T, Yagi A, Paranko J, Härkönen PL. Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB J. 1997; 11: 1297-1307.
47. Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM, Harkonen PL. Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest. 1997; 99: 618-627.
48. Untergasser G, Rumpold H, Plas E, Witkowski M, Berger P. Seminal plasma factors induce in vitro PRL secretion in smooth muscle cells of the human prostate. J Clin Endocrinol Metab. 2001; 86: 5577-5584.
49. Ishida M, Yoshida M, Fukuta S, et al. Analysis of prolactin gene expression and cleaved prolactin variants in the mouse testis and spermatozoa. J Reprod Dev. 2010; 56: 567-574.
50. Kerr J, Wood W, Ridgway EC. Basic science and clinical research advances in the pituitary transcription factors: Pit-1 and Prop-1. Curr Opin Endocrinol Diabetes Obes. 2008; 15: 359-363.
51. Maeda K, Taniuchi S, Takahashi S, Takeuchi S. Pit-1w may regulate prolactin gene expression in mouse testis. Gen Comp Endocrinol. 2012; 178: 180-184.
52. Pujianto DA, Curry BJ, Aitken RJ. Prolactin exerts a prosurvival effect on human spermatozoa via mechanisms that involve the stimulation of Akt phosphorylation and suppression of caspase activation and capacitation. Endocrinology. 2010; 151: 1269-1279.
53. Clapp C. Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms. Endocrinology. 1987; 121: 2055-2064.
54. Clapp C, Weiner RI. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology. 1992; 130: 1380-1386.
55. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology. 1993; 133: 1292-1299.
56. Martini JF, Piot C, Humeau LM, Struman I, Martial JA, Weiner RI. The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation. Mol Endocrinol. 2000; 14: 1536-1549.
57. Clapp C, López-Gómez FJ, Nava G, et al. Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects. J Endocrinol. 1998; 158: 137-144.
58. Corbacho AM, Macotela Y, Nava G, et al. Human umbilical vein endothelial cells express multiple prolactin isoforms. J Endocrinol. 2000; 166: 53-62.
59. Ochoa A, Montes de Oca P, Rivera JC, et al. Expression of prolactin gene and secretion of prolactin by rat retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 2001; 42: 1639-1645.
60. Khurana S, Liby K, Buckley AR, Ben-Jonathan N. Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin. Endocrinology. 1999; 140: 4127-4132.
61. Macotela Y, Aguilar MB, Guzmán-Morales J, et al. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin. J Cell Sci. 2006; 119: 1790-1800.
62. Clapp C, Thebault S, Martínez de la Escalera G. Hormones and postpartum cardiomyopathy. Trends Endocrinol Metab. 2007; 18: 329-330.
63. Cruz-Soto ME, Cosío G, Jeziorski MC, et al. Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules. Endocrinology. 2009; 150: 5446-5454.
64. Ge G, Fernández CA, Moses MA, Greenspan DS. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc Natl Acad Sci USA. 2007; 104: 10010-10015.
65. Clapp C, Gonzá lez C, Macotela Y, et al. Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function. Front Horm Res. 2006; 35: 64-73.
66. Wu H, Devi R, Malarkey WB. Expression and localization of prolactin messenger ribonucleic acid in the human immune system. Endocrinology. 1996; 137: 349-353.
67. Kooijman R, Gerlo S, Coppens A, Hooghe-Peters EL. Growth hormone and prolactin expression in the immune system. Ann NY Acad Sci. 2000; 917: 534-540.
68. Urtishak SL, McKenna EA, Mastro AM. Prolactin and prolactin receptor expression in rat, small intestine, intraepithelial lymphocytes during neonatal development. Dev Immunol. 2001; 8: 319-330.
69. Xu D, Lin L, Lin X, Huang Z, Lei Z. Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown. Cell Immunol. 2010; 263: 71-78.
70. Reem GH, Ray DW, Davis JR. The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP. J Mol Endocrinol. 1999; 22: 285-292.
71. Diaz L, Martínez-Reza I, García-Becerra R, Gonzá lez L, Larrea F, Méndez I. Calcitriol stimulates prolactin expression in non-activated human peripheral blood mononuclear cells: breaking paradigms. Cytokine. 2011; 55: 188-194.
72. Cejkova P, Chroma V, Cerna M, et al. Monitoring of the course of sepsis in hematooncological patients by extrapituitary prolactin expression in peripheral blood monocytes. Physiol Res. 2012; 61: 481-488.
73. Mejía S, Morales MA, Zetina ME, Martínez de la Escalera G, Clapp C. Immunoreactive prolactin forms colocalize with vasopressin in neurons of the hypothalamic paraventricular and supraoptic nuclei. Neuroendocrinology. 1997; 66: 151-159.
74. Torner L, Nava G, Dueñas Z, et al. Changes in the expression of neurohypophyseal prolactins during the estrous cycle and after estrogen treatment. J Endocrinol. 1999; 161: 423-432.
75. Suzuki S, Handa RJ. Estrogen receptor-α, but not estrogen receptor-α, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J Comp Neurol. 2005; 484: 28-42.
76. Roselli CE, Bocklandt S, Stadelman HL, Wadsworth T, Vilain E, Stormshak F. Prolactin expression in the sheep brain. Neuroendocrinology. 2008; 87: 206-215.
77. Chaiseha Y, Ngernsoungnern P, Sartsoongnoen N, Prakobsaeng N, El Halawani ME. Presence of prolactin mRNA in extra-pituitary brain areas in the domestic turkey. Acta Histochem. 2012; 114: 116-121.
78. Yang X, Meyer K, Friedl A. STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis. J Biol Chem. 2013; 288: 21184-21196.
79. Torner L, Neumann ID. The brain prolactin system: involvement in stress response adaptations in lactation. Stress. 2002; 5: 249-257.
80. Bosch OJ. Maternal nurturing is dependent on her innate anxiety: the behavioral roles of brain oxytocin and vasopressin. Horm Behav. 2011; 59: 202-212.
81. Torner L, Maloumby R, Nava G, Aranda J, Clapp C, Neumann ID. In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. Eur J Neurosci. 2004; 19: 1601-1608.
82. DeVito WJ, Stone S, Mori K. Low concentrations of ethanol inhibits prolactin-induced mitogenesis and cytokine expression in cultured astrocytes. Endocrinology. 1997; 138: 922-928.
83. Chen L, Taishi P, Duricka D, Krueger JM. Brainstem prolactin mRNA is enhanced in mice with suppressed neuronal nitric oxide synthase activity. Brain Res Mol Brain Res. 2004; 129: 179-184.
84. Foitzik K, Langan EA, Paus R. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol. 2009; 129: 1071-1087.
85. Foitzik K, Krause K, Nixon AJ, et al. Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. AmJ Pathol. 2003; 162: 1611-1621.
86. Craven AJ, Nixon AJ, Ashby MG, et al. Prolactin delays hair regrowth in mice. J Endocrinol. 2006; 191: 415-425.
87. Langan EA, Ramot Y, Hanning A, et al. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol. 2010; 162: 1127-1131.
88. Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol. 2006; 168: 748-756.
89. Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A. Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med. 2000; 136: 476-481.
90. Richards RG, Hartman SM. Human dermal fibroblast cells express prolactin in vitro. J Invest Dermatol. 1996; 106: 1250-1255.
91. Hugo ER, Borcherding DC, Gersin KS, Loftus J, Ben-Jonathan N. Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J Clin Endocrinol Metab. 2008; 93: 4006-4012.
92. Khurana S, Kuns R, Ben-Jonathan N. Heparin-binding property of human prolactin: a novel aspect of prolactin biology. Endocrinology. 1999; 140: 1026-1029.
93. Kok P, Roelfsema F, Frölich M, Meinders AE, Pijl H. Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab. 2004; 89: 4445-4449.
94. McFarland-Mancini M, Hugo E, Loftus J, Ben-Jonathan N. Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochem Biophys Res Commun. 2006; 344: 9-16.
95. Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N. LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology. 2006; 147: 306-313.
96. Marano RJ, Tickner J, Redmond SL. Age related changes in gene expression within the cochlea of C57BL/6J mice. Aging Clin Exp Res. 2012; 24: 603-611.
97. Smeti I, Assou S, Savary E, Masmoudi S, Zine A. Transcriptomic analysis of the developing and adult mouse cochlear sensory epithelia. PLoS One. 2012; 7: e42987.
98. Marano RJ, Tickner J, Redmond SL. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. PLoS One. 2013; 8: e63952.
99. Horner KC. The effect of sex hormones on bone metabolism of the otic capsule-an overview. Hear Res. 2009; 252: 56-60.